Viewing Study NCT06507995



Ignite Creation Date: 2024-10-26 @ 3:35 PM
Last Modification Date: 2024-10-26 @ 3:35 PM
Study NCT ID: NCT06507995
Status: COMPLETED
Last Update Posted: None
First Post: 2024-06-26

Brief Title: The Effectiveness of Thoracal Epidural Steroid and Local Anesthetic Injection
Sponsor: None
Organization: None

Study Overview

Official Title: The Effectiveness of Thoracal Epidural Steroid and Local Anesthetic Injection
Status: COMPLETED
Status Verified Date: 2024-07
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: No
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: The primary objective was to evaluate the effectiveness of thoracic interlaminar epidural injections in alleviating pain and enhancing function in patients suffering from chronic mid andor upper back pain

Materials and Methods One hundred patients were randomly divided into two groups each consisting of 50 patients Group I received only a local anesthetic while Group II received a combination of local anesthetic and steroids The random assignment to either Group I or Group II was determined using a simple computer-generated sequence

Outcomes were evaluated using the Numeric Rating Scale NRS and the revised Oswestry Disability Index rODI Patients who showed significant improvement for more than four weeks after the first two procedures were deemed successful Those who did not were classified as failed participants Significant improvement was defined as a reduction of more than 50 in both NRS and rODI scores with assessments conducted at baseline and at 3 6 and 12 months post-treatment

The center where the study was conducted Ankara University Faculty of Medicine Department of Anesthesiology and Reanimation Division of Algology Ankara Turkey
Detailed Description: None

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None